{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:37:49Z","timestamp":1785253069001,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the key project of military medical innovation project in 2017 and the project of monitoring and evaluation of the use of key clinical drugs","award":["17CXZ010 and Y2021FH-YWPJ01"],"award-info":[{"award-number":["17CXZ010 and Y2021FH-YWPJ01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00228-023-03492-6","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T08:03:34Z","timestamp":1681200214000},"page":"759-765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of clinical characteristics and automatic monitoring of drug-induced arrhythmias in 167,546 inpatients"],"prefix":"10.1007","volume":"79","author":[{"given":"Haili","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7456-0399","authenticated-orcid":false,"given":"Daihong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengzhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchuang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"issue":"10","key":"3492_CR1","first-page":"477","volume":"21","author":"R Bian","year":"2012","unstructured":"Bian R, Yuan J, Xu H (2012) The case-control study of the influencing factors of drug induced arrhythmias. Chin J Pharmacoepidemiol 21(10):477\u2013479","journal-title":"Chin J Pharmacoepidemiol"},{"issue":"11","key":"3492_CR2","first-page":"1281","volume":"12","author":"W Song","year":"2020","unstructured":"Song W, Liu T (2020) Interpretation of the 2020 American Heart Association scientific statement on drug-induced arrhythmias. Chin J Evid Based Cardiovasc Med 12(11):1281\u20131282","journal-title":"Chin J Evid Based Cardiovasc Med"},{"key":"3492_CR3","doi-asserted-by":"crossref","unstructured":"Tisdale JE, Chung MK, Campbell KB et al (2020) Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation 142(15):e214\u2013214e233","DOI":"10.1161\/CIR.0000000000000905"},{"key":"3492_CR4","doi-asserted-by":"crossref","unstructured":"Vanneman MW, Madhok J, Weimer JM et al (2021) Perioperative implications of the 2020 American Heart Association scientific statement on drug-induced arrhythmias-a focused review. J Cardiothorac Vasc Anesth 36(4):952\u2013961","DOI":"10.1053\/j.jvca.2021.05.008"},{"issue":"4","key":"3492_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/1074248420984082","volume":"26","author":"LN Moreland-Head","year":"2021","unstructured":"Moreland-Head LN, Coons JC, Seybert AL et al (2021) Use of disproportionality analysis to identify previously unknown drug-associated causes of cardiac arrhythmias using the Food and Drug Administration Adverse Event Reporting System (FAERS) database. J Cardiovasc Pharmacol Ther 26(4):341\u2013348","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"11","key":"3492_CR6","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1111\/bcp.14847","volume":"87","author":"X Kong","year":"2021","unstructured":"Kong X, Guo D, Liu S et al (2021) Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: a matched case-control study. Br J Clin Pharmacol 87(11):4304\u20134312","journal-title":"Br J Clin Pharmacol"},{"key":"3492_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.657853","volume":"12","author":"C Yu","year":"2021","unstructured":"Yu C, Guo D, Yao C et al (2021) Development and validation of a nomogram for predicting drug-induced acute kidney injury in hospitalized patients: a case-control study based on propensity-score matching. Front Pharmacol 12:657853","journal-title":"Front Pharmacol"},{"issue":"06","key":"3492_CR8","first-page":"382","volume":"30","author":"S Liu","year":"2021","unstructured":"Liu S, Guo D, Kong X et al (2021) Analysis of the characteristics and risk factors of suspected drug-induced allergic reactions in 201299 hospitalized patients. Chin J Pharmacoepidemiol 30(06):382\u2013387","journal-title":"Chin J Pharmacoepidemiol"},{"issue":"5","key":"3492_CR9","first-page":"277","volume":"18","author":"D Guo","year":"2021","unstructured":"Guo D, Yu C (2021) Expert consensus on automated surveillance and evaluation of clinical medication risk based on hospital information system data. Chin J Drug Appl Mon 18(5):277\u2013287","journal-title":"Chinese Journal of Drug Application and Monitoring"},{"issue":"3","key":"3492_CR10","first-page":"176","volume":"19","author":"H Guo","year":"2022","unstructured":"Guo H, Guo D, Gao A et al (2022) Establishment and validation of automatic monitoring module for drug-induced arrhythmia based on data of HIS. Chin J Drug Appl Mon 19(3):176\u2013181","journal-title":"Chinese Journal of Drug Application and Monitoring"},{"key":"3492_CR11","doi-asserted-by":"publisher","first-page":"9742754","DOI":"10.1155\/2020\/9742754","volume":"2020","author":"C Yu","year":"2020","unstructured":"Yu C, Guo D, Yao C et al (2020) Clinical characteristics of hospitalized patients with drug-induced acute kidney injury and associated risk factors: a case-control study. Biomed Res Int 2020:9742754","journal-title":"Biomed Res Int"},{"issue":"12","key":"3492_CR12","first-page":"1465","volume":"23","author":"B Li","year":"2014","unstructured":"Li B, Gao R, Li R et al (2014) Causal determination of the adverse events and adverse drug reactions in drug clinical trials. Chin J New Drugs 23(12):1465\u20131470","journal-title":"Chinese Journal of New Drugs"},{"issue":"6","key":"3492_CR13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/europace\/euz046","volume":"21","author":"DO Arnar","year":"2019","unstructured":"Arnar DO, Mairesse GH, Boriani G et al (2019) Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS). Europace 21(6):844\u2013845","journal-title":"Europace"},{"issue":"13","key":"3492_CR14","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","volume":"67","author":"PJ Schwartz","year":"2016","unstructured":"Schwartz PJ, Woosley RL (2016) Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes. J Am Coll Cardiol 67(13):1639\u20131650","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3492_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1586\/17512433.2016.1100073","volume":"9","author":"K Vlachos","year":"2016","unstructured":"Vlachos K, Georgopoulos S, Efremidis M et al (2016) An update on risk factors for drug-induced arrhythmias. Expert Rev Clin Pharmacol 9(1):117\u2013127","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"12","key":"3492_CR16","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","volume":"29","author":"KE Trinkley","year":"2013","unstructured":"Trinkley KE, Rlii P, Lien H et al (2013) QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin 29(12):1719\u20131726","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"3492_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/JXX.0000000000000348","volume":"32","author":"RJ Klotzbaugh","year":"2020","unstructured":"Klotzbaugh RJ, Martin A, Turner JR (2020) Drug-induced proarrhythmia: discussion and considerations for clinical practice. J Am Assoc Nurse Pract 32(2):1\u20137","journal-title":"J Am Assoc Nurse Pract"},{"issue":"02","key":"3492_CR18","first-page":"110","volume":"28","author":"R Tong","year":"2020","unstructured":"Tong R, He Z, Cheng M et al (2020) Effects of levofloxacin on QTc interval of the patients with type 2 diabetes mellitus and infection. Pharm Clin Res 28(02):110\u2013112","journal-title":"Pharmaceutical and Clinical Research"},{"issue":"3","key":"3492_CR19","first-page":"181","volume":"30","author":"H Guo","year":"2021","unstructured":"Guo H, Guo D, Liu S et al (2021) Analysis of 1 439 cases of drug-induced arrhythmia. Chin J Pharmacoepidemiol 30(3):181\u2013186","journal-title":"Chin J Pharmacoepidemiol"},{"key":"3492_CR20","volume":"353","author":"DAT Bulletin","year":"2016","unstructured":"Bulletin DAT (2016) QT interval and drug therapy. BMJ 353:i2732","journal-title":"BMJ"},{"issue":"3","key":"3492_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.cnc.2016.04.007","volume":"28","author":"A Lee","year":"2016","unstructured":"Lee A, Pickham D (2016) Basic cardiac electrophysiology and common drug-induced arrhythmias. Crit Care Nurs Clin North Am 28(3):357","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"11","key":"3492_CR22","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/cid\/cis664","volume":"55","author":"F Lapi","year":"2012","unstructured":"Lapi F, Wilchesky M, Kezouh A et al (2012) Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis 55(11):1457\u20131465","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3492_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40264-018-0751-2","volume":"42","author":"E Gorelik","year":"2019","unstructured":"Gorelik E, Masarwa R, Perlman A et al (2019) Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysis. Drug Saf 42(4):529\u2013538","journal-title":"Drug Saf"},{"issue":"2","key":"3492_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1574886315666200213112702","volume":"15","author":"L Shojaei","year":"2020","unstructured":"Shojaei L, Ruzbahani M, Khajavian S et al (2020) Analysis of QTc Interval during levofloxacin prescription in cardiac patients with pneumonia. Curr Drug Saf 15(2):111\u2013116","journal-title":"Curr Drug Saf"},{"key":"3492_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pharmthera.2018.04.009","volume":"189","author":"J Alexandre","year":"2018","unstructured":"Alexandre J, Moslehi JJ, Bersell KR et al (2018) Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms. Pharmacol Ther 189:89\u2013103","journal-title":"Pharmacol Ther"},{"key":"3492_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12916-015-0379-3","volume":"13","author":"AC Tricco","year":"2015","unstructured":"Tricco AC, Soobiah C, Blondal E et al (2015) Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysis. BMC Med 13:142","journal-title":"BMC Med"},{"issue":"1","key":"3492_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/cid\/cit185","volume":"57","author":"MS van Mourik","year":"2013","unstructured":"van Mourik MS, Troelstra A, van Solinge WW et al (2013) Automated surveillance for healthcare-associated infections: opportunities for improvement. Clin Infect Dis 57(1):85\u201393","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3492_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s43441-019-00027-z","volume":"54","author":"C Chen","year":"2020","unstructured":"Chen C, Jia W, Guo D et al (2020) Development of a computer-assisted adverse drug events alarm and assessment system for hospital inpatients in China. Ther Innov Regul Sci 54(1):32\u201341","journal-title":"Ther Innov Regul Sci"},{"issue":"2","key":"3492_CR29","first-page":"92","volume":"15","author":"P Hu","year":"2018","unstructured":"Hu P, Guo D, Jia W et al (2018) Intelligentialized real-time surveillance study on adverse drug reactions caused by cinepazide maleate. Chin J Drug Appl Mon 15(2):92\u201395","journal-title":"Chinese Journal of Drug Application and Monitorin"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03492-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03492-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03492-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T08:11:27Z","timestamp":1685434287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03492-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3492"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03492-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"22 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Chinese PLA General Hospital (S2018-054\u201301). All patient data were kept strictly confidential.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agree to publish in the journal \u201c<i>European Journal of Clinical Pharmacology<\/i>\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}